```html

Zygotic Twin Growth Discrepancy

What is Zygotic Twin Growth Discrepancy?

Zygotic twin growth discrepancy (also called twin growth discordancy or intra‑uterine growth restriction in twins) refers to a significant difference in size or weight between two twins that share the same uterus and originate from a single fertilized egg (monozygotic) or from two separate eggs (dizygotic). The condition is identified when one twin’s estimated fetal weight is 20 %–30 % lower than that of the co‑twin, or when the size gap exceeds two standard deviations on ultrasound measurements.

Because twins share a limited blood supply and uterine space, a discrepancy can signal that one twin is not receiving adequate nutrients or oxygen. Some degree of size difference is normal—especially in twins that are born at different times (e.g., one twin preterm). However, a pronounced discrepancy raises concerns for complications such as placental insufficiency, twin‑twin transfusion syndrome (TTTS), or chromosomal abnormalities.

Understanding the underlying cause is essential for determining whether close monitoring, medical intervention, or delivery planning is needed.

Common Causes

Several maternal, placental, and fetal factors can lead to growth disparity between twins. The most frequently reported causes include:

• Placental Insufficiency: One twin may have a smaller or less functional portion of the placenta, limiting nutrient and oxygen delivery.
• Twin‑Twin Transfusion Syndrome (TTTS): In monochorionic (shared‑placenta) twins, abnormal blood‑vessel connections cause one twin (the donor) to receive less blood.
• Selective Intrauterine Growth Restriction (sIUGR): One twin experiences growth restriction while the other grows normally.
• Chromosomal or Genetic Abnormalities: Conditions such as trisomy 21, Turner syndrome, or rare gene mutations can stunt growth.
• Congenital Anomalies: Structural problems (e.g., heart defects, gastrointestinal malformations) can increase metabolic demand and limit growth.
• Maternal Health Issues: Hypertension, pre‑eclampsia, diabetes, or severe anemia can affect uteroplacental blood flow.
• Uterine Abnormalities: Fibroids, a bicornuate uterus, or previous surgery may crowd one twin.
• Infections: Cytomegalovirus (CMV), toxoplasmosis, or other infections can impair fetal development.
• Nutrition & Lifestyle: Maternal undernutrition, smoking, or significant alcohol use can exacerbate growth problems.
• Assisted Reproductive Technologies (ART): Higher rates of multiple gestations from IVF may be associated with abnormal placentation.

Associated Symptoms

While many women with twin growth discrepancy feel completely normal, certain signs may accompany the condition or suggest worsening placental function:

• Sudden or progressive decrease in fetal movement of one twin (usually the smaller one).
• Maternal symptoms of pre‑eclampsia: headache, visual changes, swelling, or sudden weight gain.
• Persistent abdominal pain or uterine tenderness.
• Vaginal bleeding or spotting.
• Elevated blood pressure or proteinuria on prenatal labs.
• Rapidly increasing size discrepancy noted on routine ultrasounds.

When to See a Doctor

Prompt evaluation is warranted if you notice any of the following:

• Noticeable reduction in the movement of one twin compared with the other.
• New or worsening abdominal pain, especially if it is constant or radiates to the back.
• Signs of pre‑eclampsia (severe headache, vision changes, swelling, sudden weight gain).
• Vaginal bleeding, spotting, or fluid leakage.
• Rapidly widening size gap on ultrasound (e.g., growth lag >20 % in a short interval).
• Any concern that you are not following your prenatal appointment schedule.

If any of these symptoms appear, contact your obstetrician or go to the nearest emergency department. Early detection can prevent serious complications for both twins.

Diagnosis

Diagnosing twin growth discrepancy involves a combination of imaging, laboratory tests, and careful clinical assessment.

1. Serial Ultrasound Examinations

• Biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), and femur length (FL): These measurements are plotted on growth charts specific for twins.
• Doppler Studies: Umbilical artery, middle cerebral artery, and ductus venosus flow are evaluated for signs of compromised blood flow.
• Placental Assessment: Size, location, and vascular anastomoses are examined, especially in monochorionic twins.

2. Maternal Blood Tests

• Complete blood count, metabolic panel, and screening for anemia.
• Blood pressure monitoring and urine protein checks for pre‑eclampsia.
• Serology for infections (CMV, toxoplasmosis, rubella) if indicated.

3. Fetal Monitoring

• Non‑stress tests (NST) or biophysical profiles (BPP) to assess fetal heart rate patterns and well‑being.

4. Genetic Evaluation (if indicated)

• Amniocentesis or chorionic villus sampling for karyotyping when structural anomalies or growth lag are severe.

5. Maternal History & Physical Exam

• Review of underlying conditions (e.g., hypertension, diabetes), medication use, and lifestyle factors.

A multidisciplinary team—often involving maternal‑fetal medicine specialists, neonatologists, and genetic counselors—interprets these findings to guide management.

Treatment Options

Therapeutic strategies aim to improve placental perfusion, protect the growth‑restricted twin, and determine the safest timing of delivery.

1. Close Surveillance

• Biweekly (or more frequent) ultrasounds to track growth trajectories.
• Weekly Doppler studies when blood‑flow abnormalities are present.
• Regular maternal blood‑pressure checks and urine protein analysis.

2. Maternal Optimization

• Nutritional Support: High‑protein, calorie‑dense diet; prenatal vitamins with iron, folic acid, and DHA.
• Blood‑Pressure Management: Low‑dose aspirin (81 mg) after 12 weeks for high‑risk women, as recommended by the ACOG and CDC.
• Smoking Cessation & Alcohol Avoidance: Counseling or nicotine‑replacement therapy if needed.

3. In‑Utero Interventions (selected cases)

• Laser Photocoagulation: For severe TTTS, selective laser ablation of placental anastomoses can equalize blood flow.
• Selective Fetoscopic Surgery: Rarely, fetoscopic decompression of a cystic lung or shunting of a pleural effusion.
• Maternal Steroids: Betamethasone 12 mg IM 24 h apart to mature fetal lungs if preterm delivery is anticipated.

4. Delivery Planning

• Timing: If the smaller twin shows worsening Doppler indices or non‑reassuring NST, delivery may be recommended at 34–35 weeks (or earlier if urgent).
• Mode of Delivery: Vaginal delivery is possible for many twin pregnancies, but a C‑section may be advised for severe growth discordance, malpresentation, or placenta issues.
• Neonatal Preparedness: Coordinate with the NICU for immediate post‑delivery support, especially for the growth‑restricted twin.

5. Post‑Delivery Care

• Growth‑restricted newborns may need temperature regulation, glucose monitoring, and possibly respiratory support.
• Long‑term neurodevelopmental follow‑up is recommended, as sIUGR is linked to higher rates of learning difficulties.

Prevention Tips

While you cannot control all factors that lead to twin growth discrepancy, certain measures can reduce risk:

• Pre‑conception Health: Optimize weight, control chronic conditions (hypertension, diabetes), and stop smoking.
• Early Prenatal Care: First‑trimester visits allow early identification of chorionicity and placental location.
• Adhere to Recommended Screening: Routine ultrasounds at 12–14 weeks (nuchal translucency) and 18–22 weeks (anatomy scan) are critical for spotting early discordance.
• Balanced Nutrition: Follow a diet rich in lean protein, whole grains, fruits, vegetables, and adequate fluid intake.
• Avoid Substance Use: No alcohol, illicit drugs, or nicotine.
• Manage Stress: Chronic stress may affect blood pressure; consider relaxation techniques or counseling.
• Consider Single‑Embryo Transfer in IVF: When possible, limit the number of embryos transferred to reduce high‑order multiples.
• Take Low‑Dose Aspirin if Indicated: Women with a history of pre‑eclampsia or hypertension may benefit (consult your provider).

Emergency Warning Signs

If any of the following occur, seek emergency medical care immediately (call 911 or go to the nearest emergency department):

• Sudden, severe abdominal pain or uterine cramping that does NOT subside.
• Heavy vaginal bleeding (soaking a pad in < 30 minutes) or bright red clots.
• Loss of all fetal movements for more than 2 hours (especially in the smaller twin).
• Signs of pre‑eclampsia: severe headache, visual disturbances (flashing lights, blurred vision), rapid swelling of hands/face, or sudden weight gain > 2 kg in 24 h.
• Fever > 38°C (100.4°F) without an obvious cause, which may indicate infection.
• Fluid leakage (clear or pink-tinged) suggesting premature rupture of membranes.

These signs may indicate placental abruption, severe TTTS, or imminent preterm labor—all of which require urgent intervention.

---

References: Mayo Clinic. “Twin pregnancy: Complications.”; American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 169; Centers for Disease Control and Prevention (CDC) – “Twin and higher order multiple births.”; National Institutes of Health (NIH) – “Intrauterine growth restriction.”; World Health Organization (WHO) – “Maternal health guidelines.”; Cleveland Clinic – “Twin‑Twin Transfusion Syndrome.”; Recent peer‑reviewed articles in Obstetrics & Gynecology and American Journal of Obstetrics & Gynecology (2022‑2024).

```